An increasing number of probiotic strains are genomes sequenced. This provides new insight in to the potential functionalities of specific strains and their role in maintaining gastro intestinal or vaginal health.
Genome sequencing also help to identify the potential presence or absence of nucleotide sequences that are associated with undesirable traits such as virulence factors or antibiotic resistance genes, aspects that are critical for the safety.
The Ecovag® strains are genome sequenced. Genes potentially associated with adherence to VEC and antimicrobial properties have been identified and also the strains do not contain phenotypically active gene sequences associated with these negative traits.
The genome sequencing has confirmed safety and provided valuable insight into the functionalities that contribute to the efficacy of the Ecovag® strains.